Fluoropharma Medical Stock Current Ratio
| FPMI Stock | USD 0.0001 0.00 0.00% |
Fluoropharma Medical fundamentals help investors to digest information that contributes to Fluoropharma Medical's financial success or failures. It also enables traders to predict the movement of Fluoropharma Pink Sheet. The fundamental analysis module provides a way to measure Fluoropharma Medical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Fluoropharma Medical pink sheet.
Fluoropharma |
Fluoropharma Medical Company Current Ratio Analysis
Fluoropharma Medical's Current Ratio is calculated by dividing the Current Assets of a company by its Current Liabilities. It measures whether or not a company has enough cash or liquid assets to pay its current liability over the next fiscal year. The ratio is regarded as a test of liquidity for a company.
Typically, short-term creditors will prefer a high current ratio because it reduces their overall risk. However, investors may prefer a lower current ratio since they are more concerned about growing the business using assets of the company. Acceptable current ratios may vary from one sector to another, but the generally accepted benchmark is to have current assets at least as twice as current liabilities (i.e., Current Ration of 2 to 1).
| Competition |
In accordance with the recently published financial statements, Fluoropharma Medical has a Current Ratio of 0.0 times. This is 100.0% lower than that of the Biotechnology sector and 100.0% lower than that of the Health Care industry. The current ratio for all United States stocks is 100.0% higher than that of the company.
Fluoropharma Current Ratio Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Fluoropharma Medical's direct or indirect competition against its Current Ratio to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Fluoropharma Medical could also be used in its relative valuation, which is a method of valuing Fluoropharma Medical by comparing valuation metrics of similar companies.Fluoropharma Medical is currently under evaluation in current ratio category among its peers.
Fluoropharma Fundamentals
| Return On Asset | -2.35 | |||
| Current Valuation | 9.23 M | |||
| Shares Outstanding | 34.26 M | |||
| Shares Owned By Institutions | 0.34 % | |||
| Price To Earning | (0.39) X | |||
| Price To Book | 17.76 X | |||
| EBITDA | (2.16 M) | |||
| Net Income | (2.05 M) | |||
| Cash And Equivalents | 24.72 K | |||
| Total Debt | 5.82 M | |||
| Debt To Equity | 0.07 % | |||
| Book Value Per Share | (0.30) X | |||
| Cash Flow From Operations | (880.12 K) | |||
| Earnings Per Share | (0.08) X | |||
| Target Price | 2.5 | |||
| Beta | -59.92 | |||
| Market Capitalization | 3.43 M | |||
| Total Asset | 334.76 K | |||
| Retained Earnings | (34.16 M) | |||
| Working Capital | (10.23 M) | |||
| Current Asset | 89 K | |||
| Current Liabilities | 10.32 M | |||
| Net Asset | 334.76 K |
About Fluoropharma Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Fluoropharma Medical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Fluoropharma Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Fluoropharma Medical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in Fluoropharma Pink Sheet
Fluoropharma Medical financial ratios help investors to determine whether Fluoropharma Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Fluoropharma with respect to the benefits of owning Fluoropharma Medical security.